| Authors: |
Tagnères S; Molecular, Cellular and Developmental Biology unit (MCD), Centre de Biologie Integrative (CBI), Team with an accreditation from the French 'Ligue contre le Cancer' organism., University of Toulouse, CNRS, UPS, 118 route de Narbonne, Toulouse, Cedex, France., Santo PE; Molecular, Cellular and Developmental Biology unit (MCD), Centre de Biologie Integrative (CBI), Team with an accreditation from the French 'Ligue contre le Cancer' organism., University of Toulouse, CNRS, UPS, 118 route de Narbonne, Toulouse, Cedex, France., Radermecker J; Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR5286, Université de Lyon, Université Claude Bernard Lyon 1, Centre Léon Bérard, CEDEX 08, Lyon, France., Rinaldi D; Molecular, Cellular and Developmental Biology unit (MCD), Centre de Biologie Integrative (CBI), Team with an accreditation from the French 'Ligue contre le Cancer' organism., University of Toulouse, CNRS, UPS, 118 route de Narbonne, Toulouse, Cedex, France., Froment C; Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III-Paul Sabatier (UPS), Toulouse, France.; Infrastructure Nationale de Protéomique, ProFI, Toulouse, France., Provost Q; Molecular, Cellular and Developmental Biology unit (MCD), Centre de Biologie Integrative (CBI), Team with an accreditation from the French 'Ligue contre le Cancer' organism., University of Toulouse, CNRS, UPS, 118 route de Narbonne, Toulouse, Cedex, France., Bongers M; Molecular, Cellular and Developmental Biology unit (MCD), Centre de Biologie Integrative (CBI), Team with an accreditation from the French 'Ligue contre le Cancer' organism., University of Toulouse, CNRS, UPS, 118 route de Narbonne, Toulouse, Cedex, France., Capeille S; Molecular, Cellular and Developmental Biology unit (MCD), Centre de Biologie Integrative (CBI), Team with an accreditation from the French 'Ligue contre le Cancer' organism., University of Toulouse, CNRS, UPS, 118 route de Narbonne, Toulouse, Cedex, France., Watkins N; Biosciences Institute, The Medical School, Newcastle University, Newcastle upon Tyne, UK., Marcoux J; Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III-Paul Sabatier (UPS), Toulouse, France.; Infrastructure Nationale de Protéomique, ProFI, Toulouse, France., Gleizes PE; Molecular, Cellular and Developmental Biology unit (MCD), Centre de Biologie Integrative (CBI), Team with an accreditation from the French 'Ligue contre le Cancer' organism., University of Toulouse, CNRS, UPS, 118 route de Narbonne, Toulouse, Cedex, France., Marcel V; Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR5286, Université de Lyon, Université Claude Bernard Lyon 1, Centre Léon Bérard, CEDEX 08, Lyon, France., Plisson-Chastang C; Molecular, Cellular and Developmental Biology unit (MCD), Centre de Biologie Integrative (CBI), Team with an accreditation from the French 'Ligue contre le Cancer' organism., University of Toulouse, CNRS, UPS, 118 route de Narbonne, Toulouse, Cedex, France., Lebaron S; Molecular, Cellular and Developmental Biology unit (MCD), Centre de Biologie Integrative (CBI), Team with an accreditation from the French 'Ligue contre le Cancer' organism., University of Toulouse, CNRS, UPS, 118 route de Narbonne, Toulouse, Cedex, France. simon.lebaron@univ-tlse3.fr.; Institut national de la santé et de la recherche médicale (INSERM), Paris, France. simon.lebaron@univ-tlse3.fr. |
